secwatch.observer — SEC 8-K summary
======================================

Issuer:     Context Therapeutics Inc. (CNTX)
CIK:        0001842952
Form:       8-K
Filed at:   2024-03-21T23:59:59+00:00
Accession:  0001842952-24-000010
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Context Therapeutics amends bylaws to reduce quorum to one-third, update proxy rules
--------------------------------------------------------------------------------

- Quorum reduced to one-third of outstanding shares entitled to vote, effective immediately.
- Stockholder list at meetings no longer required; notice rules for director nominations updated.
- Proxies soliciting under Rule 14a-19 must certify compliance and provide evidence 5 days before meeting.
- Non-compliant nominations deemed void; white proxy cards reserved for Board of Directors only.
- Technical, clarifying and conforming changes also adopted.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1842952/000184295224000010/0001842952-24-000010-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1842952/000184295224000010/cntx-20240319.htm
  HTML page:      https://secwatch.observer/filing/0001842952-24-000010

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer